TRIDENT LIFELINE
Back to Balance Sheet
|
TRIDENT LIFELINE Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹-1.94 Cr | ₹-0.15 Cr | ₹-0.52 Cr | ₹-1.04 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of TRIDENT LIFELINE ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹-1.94 Cr |
| Mar2024 | ₹-0.15 Cr |
| Mar2023 | ₹-0.52 Cr |
| Mar2022 | ₹-1.04 Cr |
How is Deferred Tax Assets / Liabilities of TRIDENT LIFELINE Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-1.94 Cr | Negative | |
| Mar2024 | ₹-0.15 Cr | Negative | |
| Mar2023 | ₹-0.52 Cr | Negative | |
| Mar2022 | ₹-1.04 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of TRIDENT LIFELINE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TRIDENT LIFELINE | ₹351.7 Cr | -3.4% | 2.9% | -6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹433,068.0 Cr | -0.7% | 7.4% | -0.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹171,847.0 Cr | -0.1% | -4.8% | 3.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹127,985.0 Cr | 2.2% | 6.3% | 11.4% | Stock Analytics | |
| CIPLA | ₹122,826.0 Cr | -0.6% | 1.2% | NA | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,418.0 Cr | 1.5% | 6.4% | 4.8% | Stock Analytics | |
TRIDENT LIFELINE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TRIDENT LIFELINE | -3.4% |
2.9% |
-6% |
| SENSEX | -0.5% |
1.5% |
6.9% |
You may also like the below Video Courses